Edition:
India

Editas Medicine Inc (EDIT.OQ)

EDIT.OQ on NASDAQ Stock Exchange Global Select Market

24.99USD
20 Sep 2019
Change (% chg)

-- (--)
Prev Close
$24.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
225,596
52-wk High
$33.72
52-wk Low
$17.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 2.33 -0.689
Mar '19 2.07 -0.599
FY 2018 Dec '18 6.12 -0.522
Sep '18 14.52 -0.321
Jun '18 7.37 -0.825
Mar '18 3.93 -0.673
FY 2017 Dec '17 3.67 -0.849
Sep '17 6.28 -0.644
Jun '17 3.10 -0.648
Mar '17 0.68 -0.852
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 6 4.72 8.80 2.00 9.47
Quarter Ending Dec-19 6 5.77 8.80 2.00 15.13
Year Ending Dec-19 7 19.03 39.03 8.40 31.06
Year Ending Dec-20 8 24.30 41.40 7.53 30.01
Earnings (per share)
Quarter Ending Sep-19 7 -0.72 -0.67 -0.79 -0.86
Quarter Ending Dec-19 7 -0.76 -0.68 -0.89 -1.00
Year Ending Dec-19 7 -2.75 -2.64 -2.84 -3.31
Year Ending Dec-20 8 -3.00 -2.68 -3.36 -3.54
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 271.58 -- --
EPS (TTM) % -46.99 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Editas Medicine Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 24.49 20.20 99 --
13 Week 45.58 38.49 99 --
26 Week 19.67 10.57 99 --
52 Week 66.62 41.23 99 --
YTD 54.10 35.33 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 81.56%
# of Holders: 263
Total Shares Held: 40,385,715
3 Mo. Net Change: 1,241,436
# New Positions: 33
# Closed Positions: 37
# Increased Positions: 112
# Reduced Positions: 101
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.